|
US6713045B1
(en)
|
1995-06-02 |
2004-03-30 |
Research Corporation Technologies, Inc. |
Targeted magnetic resonance imaging agents for the detection of physiological processes
|
|
US6770261B2
(en)
*
|
1995-06-02 |
2004-08-03 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the detection of physiological agents
|
|
US5900228A
(en)
|
1996-07-31 |
1999-05-04 |
California Institute Of Technology |
Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
|
|
US6675035B1
(en)
*
|
1997-06-20 |
2004-01-06 |
Imaging Diagnostic Systems, Inc. |
Phantom for optical and magnetic resonance imaging quality control
|
|
EP1019094B1
(en)
*
|
1997-10-02 |
2003-11-19 |
Epix Medical, Inc. |
Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
|
|
CA2307332C
(en)
*
|
1997-10-27 |
2008-09-16 |
California Institute Of Technology |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
US6713046B1
(en)
|
1997-10-27 |
2004-03-30 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
EP1032430A2
(en)
|
1997-11-17 |
2000-09-06 |
Research Corporation Technologies, Inc. |
Magnetic resonance imaging agents for the detection of physiological agents
|
|
IT1297034B1
(it)
*
|
1997-12-30 |
1999-08-03 |
Bracco Spa |
Acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
|
|
IT1297035B1
(it)
*
|
1997-12-30 |
1999-08-03 |
Bracco Spa |
Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
|
|
US6167297A
(en)
|
1999-05-05 |
2000-12-26 |
Benaron; David A. |
Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
|
|
US6230586B1
(en)
*
|
1999-05-21 |
2001-05-15 |
Chung-Hsi Chang |
Electric drive device for a bicycle
|
|
PL353336A1
(en)
|
1999-07-29 |
2003-11-17 |
Epix Medical, Inc. |
Targeting multimeric imaging agents through multilocus binding
|
|
AU2001231090A1
(en)
*
|
2000-01-22 |
2001-07-31 |
Epix Medical, Inc. |
Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavage
|
|
US6656448B1
(en)
*
|
2000-02-15 |
2003-12-02 |
Bristol-Myers Squibb Pharma Company |
Matrix metalloproteinase inhibitors
|
|
US20040146463A1
(en)
*
|
2000-05-04 |
2004-07-29 |
Meade Thomas J. |
Functional MRI agents for cancer imaging
|
|
WO2001082795A2
(en)
*
|
2000-05-04 |
2001-11-08 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
US6673333B1
(en)
*
|
2000-05-04 |
2004-01-06 |
Research Corporation Technologies, Inc. |
Functional MRI agents for cancer imaging
|
|
WO2001089584A2
(en)
*
|
2000-05-23 |
2001-11-29 |
Amersham Health As |
Contrast agents
|
|
US6748259B1
(en)
|
2000-06-15 |
2004-06-08 |
Spectros Corporation |
Optical imaging of induced signals in vivo under ambient light conditions
|
|
AU2001276956A1
(en)
|
2000-07-17 |
2002-01-30 |
California Institute Of Technology |
Macrocyclic mri contrast agents
|
|
US7029655B2
(en)
|
2000-10-04 |
2006-04-18 |
California Institute Of Technology |
Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
|
|
US20030004236A1
(en)
*
|
2001-04-20 |
2003-01-02 |
Meade Thomas J. |
Magnetic resonance imaging agents for detection and delivery of therapeutic agents and detection of physiological substances
|
|
US20020197648A1
(en)
*
|
2001-05-02 |
2002-12-26 |
Silva Robin M. |
High throughput screening methods using magnetic resonance imaging agents
|
|
TWI221406B
(en)
|
2001-07-30 |
2004-10-01 |
Epix Medical Inc |
Systems and methods for targeted magnetic resonance imaging of the vascular system
|
|
US7794693B2
(en)
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
|
US8623822B2
(en)
|
2002-03-01 |
2014-01-07 |
Bracco Suisse Sa |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
|
WO2004065621A1
(en)
|
2002-03-01 |
2004-08-05 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
|
WO2003074005A2
(en)
|
2002-03-01 |
2003-09-12 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
|
US20030198597A1
(en)
*
|
2002-04-22 |
2003-10-23 |
Meade Thomas J. |
Novel macrocyclic activatible magnetic resonance imaging contrast agents
|
|
ATE400302T1
(de)
*
|
2002-07-22 |
2008-07-15 |
Bracco Imaging Spa |
Zellmarkierungsverfahren mit paramagnetischen komplexen für mrt-anwendungen
|
|
US20050163821A1
(en)
*
|
2002-08-02 |
2005-07-28 |
Hsing-Wen Sung |
Drug-eluting Biodegradable Stent and Delivery Means
|
|
US7226577B2
(en)
|
2003-01-13 |
2007-06-05 |
Bracco Imaging, S. P. A. |
Gastrin releasing peptide compounds
|
|
US20050214859A1
(en)
|
2003-03-03 |
2005-09-29 |
Dyax Corp. |
Peptides that specifically bind HGF receptor (cMet) and uses thereof
|
|
EP2338525A3
(en)
*
|
2003-07-09 |
2011-08-03 |
California Pacific Medical Center |
Remote detection of substance delivery to cells
|
|
US20050106100A1
(en)
*
|
2003-09-03 |
2005-05-19 |
Harris Thomas D. |
Compounds containing matrix metalloproteinase substrates and methods of their use
|
|
US20050124008A1
(en)
*
|
2003-12-05 |
2005-06-09 |
Kauvar Lawrence M. |
Homogeneous competition assays
|
|
NO20035683D0
(no)
*
|
2003-12-18 |
2003-12-18 |
Amersham Health As |
Optisk avbildning av prostatakreft
|
|
FR2868320B1
(fr)
*
|
2004-03-31 |
2007-11-02 |
Centre Nat Rech Scient Cnrse |
Agent de contraste pour l'imagerie par resonance magnetique
|
|
US20060204539A1
(en)
*
|
2005-03-11 |
2006-09-14 |
Anthony Atala |
Electrospun cell matrices
|
|
EP1863546B1
(en)
|
2005-03-11 |
2015-10-07 |
Wake Forest University Health Sciences |
Production of tissue engineered heart valves
|
|
US8728463B2
(en)
*
|
2005-03-11 |
2014-05-20 |
Wake Forest University Health Science |
Production of tissue engineered digits and limbs
|
|
US20060204445A1
(en)
*
|
2005-03-11 |
2006-09-14 |
Anthony Atala |
Cell scaffold matrices with image contrast agents
|
|
EP1863547B1
(en)
*
|
2005-03-11 |
2016-05-11 |
Wake Forest University Health Sciences |
Tissue engineered blood vessels
|
|
US7531503B2
(en)
*
|
2005-03-11 |
2009-05-12 |
Wake Forest University Health Sciences |
Cell scaffold matrices with incorporated therapeutic agents
|
|
EP1743658A1
(en)
|
2005-07-14 |
2007-01-17 |
Schering Aktiengesellschaft |
Optical imaging of rheumatoid arthritis
|
|
KR20080022588A
(ko)
*
|
2005-06-30 |
2008-03-11 |
브리스톨-마이어스 스퀴브 파마 컴퍼니 |
영상화제로서의 히드라지드 컨쥬게이트
|
|
US9339559B2
(en)
*
|
2005-09-09 |
2016-05-17 |
Georgia State University Research Foundation, Inc. |
Targeted contrast agents and methods for targeting contrast agents
|
|
US20070293656A1
(en)
*
|
2005-12-29 |
2007-12-20 |
Epix Pharmaceuticals, Inc. |
Collagen binding peptides
|
|
PL2187965T3
(pl)
|
2007-08-17 |
2020-05-18 |
Purdue Research Foundation |
Koniugaty wiążący psma ligand-łącznik i sposoby ich zastosowania
|
|
WO2009054327A1
(ja)
*
|
2007-10-22 |
2009-04-30 |
Osaka Foundation For Trade And Industry |
Ｍｒｉ用プローブ
|
|
US20120045393A1
(en)
|
2009-03-17 |
2012-02-23 |
Linder Karen E |
Lhrh-ii peptide analogs
|
|
WO2010121133A2
(en)
|
2009-04-17 |
2010-10-21 |
The General Hospital Corporation |
Multimodal imaging of fibrin
|
|
WO2010108063A1
(en)
|
2009-03-19 |
2010-09-23 |
Wyeth Llc |
Methods for the preparation of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)ethyl]phosphonic acid and precursors thereof
|
|
JP2011026294A
(ja)
|
2009-06-26 |
2011-02-10 |
Canon Inc |
化合物
|
|
WO2011035140A1
(en)
|
2009-09-18 |
2011-03-24 |
Paka Pulmonary Pharmaceuticals, Inc. |
Methods and compositions for delivery of contrast moieties to the lungs
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
CN102188722A
(zh)
*
|
2010-03-18 |
2011-09-21 |
中国科学院福建物质结构研究所 |
一种含二价铁的磁共振成像造影剂
|
|
US8192429B2
(en)
|
2010-06-29 |
2012-06-05 |
Theravant, Inc. |
Abnormality eradication through resonance
|
|
AU2012282678B2
(en)
|
2011-07-11 |
2016-03-03 |
California Institute Of Technology |
Akt-specific capture agents, compositions, and methods of using and making
|
|
WO2013131994A2
(en)
*
|
2012-03-08 |
2013-09-12 |
Thommen Medical Ag |
Coating for the diagnosis of inflammatory tissues in dental applications
|
|
US9669111B2
(en)
|
2012-03-08 |
2017-06-06 |
Thommen Medical Ag |
Device for the diagnosis of inflammatory tissues in dental applications
|
|
MY171561A
(en)
|
2012-11-15 |
2019-10-18 |
Endocyte Inc |
Conjugates for treating diseases caused by psma expressing cells
|
|
US10092679B2
(en)
|
2013-10-18 |
2018-10-09 |
Wake Forest University Health Sciences |
Laminous vascular constructs combining cell sheet engineering and electrospinning technologies
|
|
GEP20237479B
(en)
|
2013-10-18 |
2023-03-27 |
Deutsches Krebsforsch |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
EP3069147A4
(en)
|
2013-11-14 |
2017-10-11 |
Endocyte, Inc. |
Compounds for positron emission tomography
|
|
WO2015171543A1
(en)
|
2014-05-05 |
2015-11-12 |
California Institute Of Technology |
Mutant akt-specific capture agents, compositions, and methods of using and making
|
|
US10471162B2
(en)
|
2014-06-20 |
2019-11-12 |
The General Hospital Corporation |
Collagen targeted imaging probes
|
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
|
US9913875B2
(en)
|
2015-03-16 |
2018-03-13 |
California Institute Of Technology |
Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
|
|
WO2017011769A2
(en)
|
2015-07-15 |
2017-01-19 |
California Institute Of Technology |
Il-17f-specific capture agents, compositions, and methods of using and making
|
|
US20170319722A1
(en)
|
2016-04-04 |
2017-11-09 |
Indi Molecular, Inc. |
Cd8-specific capture agents, compositions, and methods of using and making
|
|
WO2018064597A1
(en)
|
2016-09-29 |
2018-04-05 |
Indi Molecular, Inc. |
Compositions for detection, inhibition and imaging of indoleamine 2,3-dioxygenase 1 (ido1) and methods of making and using same
|
|
WO2018085375A1
(en)
|
2016-11-01 |
2018-05-11 |
Ohio State Innovation Foundation |
Methods for the iodination of biomolecules
|
|
AU2018258345A1
(en)
*
|
2017-04-27 |
2019-10-17 |
The Regents Of The University Of California |
Modified mri contrast agents and uses thereof
|
|
WO2018232345A1
(en)
|
2017-06-15 |
2018-12-20 |
Indi Molecular, Inc. |
Il-17f and il-17a-specific capture agents, compositions, and methods of using and making
|
|
WO2019075213A1
(en)
*
|
2017-10-11 |
2019-04-18 |
Northwestern University |
HEPARIN CONJUGATED TO PEPTIDES BINDING TO COLLAGEN FOR TARGETING BIOLOGICAL AND SYNTHETIC FABRICS
|
|
CN108314695B
(zh)
*
|
2018-01-04 |
2020-06-16 |
南京邮电大学 |
一种异种双核金属配合物的制备及应用
|
|
SG11202010217YA
(en)
|
2018-04-17 |
2020-11-27 |
Endocyte Inc |
Methods of treating cancer
|
|
WO2020093055A2
(en)
|
2018-11-02 |
2020-05-07 |
Indi Molecular, Inc. |
Peptide libraries with non-canonical amino acids
|
|
WO2020097531A1
(en)
|
2018-11-08 |
2020-05-14 |
Indi Molecular, Inc. |
Theranostic capture agents, compositions, and methods of using and making
|
|
US20200291391A1
(en)
|
2019-03-12 |
2020-09-17 |
Indi Molecular, Inc. |
Cross-linked epitopes and methods of use thereof
|
|
US12201679B2
(en)
|
2019-04-05 |
2025-01-21 |
Institute For Systems Biology |
Epitope-targeted peptide immunostimulants
|
|
US20220218834A1
(en)
|
2019-05-20 |
2022-07-14 |
Ohio State Innovation Foundation |
Apohemoglobin-haptoglobin complexes and methods of using thereof
|
|
US12473265B2
(en)
|
2019-05-20 |
2025-11-18 |
Endocyte, Inc. |
Methods for preparing PSMA conjugates
|
|
US12216122B2
(en)
|
2019-05-20 |
2025-02-04 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
|
|
US11414460B2
(en)
|
2019-07-19 |
2022-08-16 |
Institute For Systems Biology |
KRAS-specific capture agents, compositions, and methods of making and using
|
|
CN112891566A
(zh)
*
|
2019-12-04 |
2021-06-04 |
中国科学院宁波工业技术研究院慈溪生物医学工程研究所 |
一种纳米材料及其制备方法和包含其的造影剂
|
|
IL297806A
(en)
|
2020-04-30 |
2022-12-01 |
Sairopa B V |
Anti-cd103 antibodies
|
|
US12209142B2
(en)
|
2020-05-29 |
2025-01-28 |
Institute For Systems Biology |
SARS-CoV-2 epitope-targeted peptide immunostimulants
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
CN120093699B
(zh)
*
|
2025-03-06 |
2025-11-14 |
浙江大学 |
用于定位并稳定动脉粥样硬化斑块的诊疗分子、纳米粒及其制备方法
|